Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: Comparison with standard cryopreserved allografts

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 1, 2003, Pages 247-252

  Hawkins, John A ^a   Hillman, Neal D ^a   Lambert, Linda M ^a   Jones, Jamison ^a   Di Russo, Gregory B ^a   Profaizer, Tracie ^b   Fuller, Thomas C ^b   Minich, L LuAnn ^a   Williams, Richard V ^a   Shaddy, Robert E ^a   Mayer Jr , John E ^c   Ring, W Steves ^c   Jacobs, Marshall L ^c  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HOSPITAL   (United States)

^c Primary Children's Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLOGRAFT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FLOW CYTOMETRY; HEART SURGERY; HEMODYNAMICS; HUMAN; IMMUNOGENICITY; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCHOOL CHILD; SURGICAL TECHNIQUE; TISSUE GROWTH;

EID: 0041341974     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00116-8     Document Type: Article

References (26)

1. Cochran RP, Kunzelman KS. Cryopreservation does not alter antigenic expression of aortic allografts. J Surg Res. 1989;46:597-9.
2. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg. 1995;60(2 Suppl):S127-30.
3. Shaddy RE, Hunter DD, Osborne KA, Lambert LM, Minich LL, Hawkins JA, et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation. 1996;94:1063-7.
4. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999;11:194-200.
5. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg. 2001;71(5 Suppl): S428-32.
6. Elkins RC, Lane MM, Capps SB, McCue C, Dawson PE. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg. 2001;4:82-6.
7. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111-7.
8. Hawkins JA, Bailey WW, Dillon T, Schwartz DC. Midterm results with cryopreserved allograft valved conduits from the right ventricle to pulmonary arteries. J Thorac Cardiovasc Surg. 1992;104:910-6.
9. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg. 1993;105:934-42.
10. Hawkins JA, Breinholt JP, Fuller TC, Lambert LM, McGough EC, Shaddy RE. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg. 2000;119:324-30.
11. Breinholt JP, Hawkins JA, Lambert LM, Fuller TC, Profaizer T, Shaddy RE. A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery. Circulation. 2000;102(Suppl 3):111179-82.
12. McNally RT, Heacox AE, Brockbank KG. Short-term follow-up of cryopreserved allograft valves and valved conduits from the CryoLife clinical registry. In: Yankah AC, Hetzer R, Miller DC, et al, editors. Cardiac valve allografts 1962-1987. Darmstadt, Germany: Steinkopff Verlag: 1988. p. 323-32.
13. Heacox AE, McNally RT, Brockbank KG. Factors affecting the viability of cryopreserved allograft heart valves. In: Yankah AC, Hetzer R, Miller DC, et al, editors. Cardiac valve allografts 1962-1987. Darmstadt, Germany: Steinkopff Verlag; 1988. p. 37-42.
14. McNally RT, Heacox A, Brockbank KG, Bank HL, inventors. Method for Cryopreserving Heart Valves. Cryolife, Inc., Assignee. Jan 2, 1987, US patent 4,890,457.
15. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337:1861-9.
16. Pei R, Wang G, Tarsitani C, Rojo S, Chen T, Takemura S, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol. 1998;59:313-22.
17. Williams RV, Minich LL, Shaddy RE, Pagotto LT, Tani LY. Comparison of Doppler echocardiography to angiography for determining the severity of pulmonary regurgitation. Am J Cardiol. 2002;89:1438-41.
18. O'Brien M, Stafford E, Gardner M, Pohlner P, McGiffin D. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves with a note on chromosomal studies. J Thorac Cardiovasc Surg. 1987;94:812-23.
19. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. Ann Thorac Surg. 1998;66(6 Suppl):S212-5.
20. Hoekstra F, Knoop C, Vaessen L, Wassenaar C, Jutte N, Bos E, et al. Donor-specific cellular immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg. 1996;112:281-6.
21. Hoekstra F, Witvliet M, Knoop C, Akkersdijk G, Jutte N, Bogers A, et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant. 1997;16:570-2.
22. Hoekstra FM, Witvliet M, Knoop CY, Wassenaar C, Bogers AJ, Weimar W, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Am Thorac Surg. 1998;66:2022-6.
23. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation. 1992;53:1358-62.
24. Suciu-Foca N, Reed E, Marboe C, Harris P, Yu PX, Sun YK, et al. The role of anti-HLA antibodies after heart transplantation. Transplantation. 1991;51:716-24.
25. Shaddy RE, Hunter DD, Osborn KA, Hawkins JA, Fuller TC. Persistence of anti-HLA antibodies beyond one year in children receiving cryopreserved valved allografts at surgery. Am J Cardiol. 1997;80:358-9.
26. Shaddy RE, Lambert LM, Fuller TC, Profaizer T, Thompson DD, Baker SI, et al. A prospective randomized trial of azathioprine in children receiving cryopreserved valved allografts for repair of congenital heart defects. Ann Thorac Surg. 2001;71:43-7.